The impact of COVID-19 and COVID vaccination on cardiovascular outcomes

Author:

Akhtar Zubair12,Trent Mallory1,Moa Aye1,Tan Timothy C345,Fröbert Ole6789,MacIntyre C Raina1ORCID

Affiliation:

1. Biosecurity Program, The Kirby Institute, University of New South Wales (UNSW) , 2052, Sydney Australia

2. Programme on Emerging Infections, Infectious Diseases Division, icddr,b , Dhaka , Bangladesh 1212

3. Department of Cardiology, Blacktown Hospital, University of Western Sydney , 2148, Blacktown, NSW , Australia

4. School of Medical Sciences, Faculty of Medicine, University of New South Wales , 2052, Sydney, NSW , Australia

5. Department of Cardiology, Westmead Hospital, Sydney University , 2145, Westmead, NSW , Australia

6. Department of Cardiology, Faculty of Medicine and Health, Örebro University , Örebro 8200 , Sweden

7. Department of Clinical Medicine, Faculty of Health, Aarhus University , Aarhus , Denmark

8. Department of Clinical Pharmacology, Aarhus University Hospital , Arhus , Denmark

9. Steno Diabetes Center Aarhus, Aarhus University Hospital , Arhus , Denmark

Abstract

AbstractCOVID-19 is an independent risk factor for cardiovascular disease. COVID-19 vaccination may prevent this, but in some cases, COVID-19 vaccination may cause myocarditis or pericarditis. Patients with COVID-19 may present with non-specific symptoms that have a cardiac origin. This review examines the cardiovascular complications of COVID-19 infection and the impact of COVID-19 vaccination. COVID-19 cardiovascular complications include myocardial injury, pericarditis, coagulopathy, myocardial infarction, heart failure, arrhythmias, and persistent post-acute risk of adverse cardiovascular outcomes. Diagnostic and referral pathways for non-specific symptoms, such as dyspnoea and fatigue, remain unclear. COVID-19 vaccination is cardioprotective overall but is associated with myopericarditis in young males, though at a lower rate than following SARS-CoV-2 infection. Increased awareness among primary care physicians of potential cardiovascular causes of non-specific post-COVID-19 symptoms, including in younger adults, such as fatigue, dyspnoea, and chest pain, is essential. We recommend full vaccination with scheduled booster doses, optimal management of cardiovascular risk factors, rapid treatment of COVID-19, and clear diagnostic, referral, and management pathways for patients presenting with non-specific symptoms to rule out cardiac complications.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3